Acute effect on satiety, resting energy expenditure, respiratory quotient, glucagon-like peptide-1, free fatty acids, and glycerol following consumption of a combination of bioactive food ingredients in overweight subjects

J Am Coll Nutr. 2013;32(1):41-9. doi: 10.1080/07315724.2013.767667.

Abstract

Objective: A combination of bioactive food ingredients (capsaicinoids, epigallocatechin gallate, piperin, and l-carnitine, CBFI) may promote satiety and thermogenesis. The study was conducted in order to assess whether there is any effect on satiety, resting energy expenditure (REE), respiratory quotient, glucagon-like peptide-1 (GLP-1), free fatty acids (FFA) and glycerol release, following a standardized mixed meal with or without single consumption of a CBFI.

Design: An 8-week randomized double-blind placebo-controlled trial.

Setting: Dietetic and Metabolic Unit, Azienda di Servizi alla Persona, University of Pavia and "Villa delle Querce" Clinical Rehabilitation Institute, Rome, Italy.

Participants: Thirty-seven overweight adults (body mass index [BMI]: 25-35).

Intervention: Nineteen overweight subjects were included in the supplemented group (14 women, 5 men; age 46.4 ± 6.4; BMI: 30.5 ± 3.3) and 18 in the placebo group (13 women, 5 men; age 40.8 ± 11.5; BMI: 30.1 ± 2.6). Satiety was assessed using 100-mm visual analogue scales (VAS) and the area under the curve was calculated.

Results: All measured parameters increased significantly in comparison with baseline in response to meal, both with CBFI and with placebo. However, throughout the study day, the supplemented group experienced a significantly greater increase than the placebo group in their sensation of satiety following acute administration of the supplement.

Conclusion: CBFI may therefore be of great value in the treatment of overweight patients by increasing satiety and stimulating thermogenesis.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Alkaloids / pharmacology
  • Alkaloids / therapeutic use
  • Area Under Curve
  • Basal Metabolism / drug effects*
  • Benzodioxoles / pharmacology
  • Benzodioxoles / therapeutic use
  • Capsaicin / analogs & derivatives
  • Capsaicin / pharmacology
  • Capsaicin / therapeutic use
  • Carnitine / pharmacology
  • Carnitine / therapeutic use
  • Catechin / analogs & derivatives
  • Catechin / pharmacology
  • Catechin / therapeutic use
  • Dietary Supplements*
  • Double-Blind Method
  • Fatty Acids, Nonesterified / blood*
  • Female
  • Glucagon-Like Peptide 1 / blood*
  • Glycerol / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Obesity / blood
  • Obesity / drug therapy*
  • Phytotherapy
  • Piperidines / pharmacology
  • Piperidines / therapeutic use
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use
  • Polyunsaturated Alkamides / pharmacology
  • Polyunsaturated Alkamides / therapeutic use
  • Satiation / drug effects*
  • Satiety Response

Substances

  • Alkaloids
  • Benzodioxoles
  • Fatty Acids, Nonesterified
  • Piperidines
  • Plant Extracts
  • Polyunsaturated Alkamides
  • Glucagon-Like Peptide 1
  • Catechin
  • epigallocatechin gallate
  • Glycerol
  • Capsaicin
  • Carnitine
  • piperine